Main page content

Displaying results 1 - 7 of 7
Publication ID: SMA15-3583
Published:

This guide serves as a reference for substance use treatment practitioners. It offers "how to" information divided into sections. The guide is based entirely on "Substance Abuse Treatment and Domestic Violence," number 25 in the Treatment Improvement Protocol (TIP) Series.

Publication ID: SMA15-4912
Published:

This guide has information for providers and administrators on caring for people who have experienced trauma or are at risk of developing traumatic stress reactions. It also addresses prevention, intervention, and treatment issues and strategies.

Publication ID: SMA13-4788
Published:

This quick guide helps administrators of substance use disorder treatment facilities implement programs and services that address the needs of women living with substance use disorders. It addresses patterns of use and the drug screening and treatment needs of women.

Publication ID: SMA12-4097
Published:

This manual presents guidelines for enhancing motivation among patients in treatment for alcohol and substance misuse. It describes several motivational approaches, ways to integrate these approaches, and two assessment tools.

Publication ID: SMA12-3581
Published:

This manual guides clinicians through stages of primary care for alcohol and substance misuse in adult patients. It discusses warning signs of misuse, screening and follow-up, brief intervention, assessment, treatment models, and legal issues. It includes four screening tools.

Publication ID: SMA10-4531
Published:

This manual offers mental health professionals models and techniques for working with people living with co-occurring disorders. It describes screening and assessment and lists five guiding principles for effective management.

Publication ID: SMA10-4542
Published:

This manual guides counselors in the use of medications to help clients achieve abstinence from alcohol. It describes how the medications work and whom may benefit. It also presents the side effects of three FDA-approved medications: acamprosate, disulfiram, and naltrexone.